You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

Investigational Drug Information for Eldecalcitol


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Eldecalcitol?

Eldecalcitol is an investigational drug.

There have been 6 clinical trials for Eldecalcitol. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2023.

The most common disease conditions in clinical trials are Osteoporosis, Osteoporosis, Postmenopausal, and Bone Diseases, Metabolic. The leading clinical trial sponsors are Shinshu University, Chugai Pharma China Co., Ltd., and Wenzhou Haihe Pharmaceutical Co., Ltd.

There are four US patents protecting this investigational drug and one hundred and fifty-three international patents.

Recent Clinical Trials for Eldecalcitol
TitleSponsorPhase
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild OsteoporosisChugai Pharma China Co., Ltd.Phase 4
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild OsteoporosisShanghai Jiao Tong University Affiliated Sixth People's HospitalPhase 4
Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.Chugai Pharma China Co., Ltd.Phase 4

See all Eldecalcitol clinical trials

Clinical Trial Summary for Eldecalcitol

Top disease conditions for Eldecalcitol
Top clinical trial sponsors for Eldecalcitol

See all Eldecalcitol clinical trials

US Patents for Eldecalcitol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Eldecalcitol ⤷  Sign Up Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign Up
Eldecalcitol ⤷  Sign Up Pharmaceutical propylene glycol solvate compositions McNeil-PPC, Inc. (Skillman, NJ) ⤷  Sign Up
Eldecalcitol ⤷  Sign Up Pharmaceutical co-crystal compositions University of South Florida (Tampa, FL) The Regents of the University of Michigan (Ann Arbor, MI) Transform Pharmaceuticals, Inc. (Lexington, MA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.